Benefit vs cost: cancer drug 'value' tool unveiled
This article was originally published in SRA
The American Society of Clinical Oncology asked the question "What is a cancer drug's true value?" and in four very specific treatment situations the organization's Value in Cancer Care Task Force supplied an answer: It depends.
Register for our free email digests: